In PCa, we found NSD2 to be exclusively expressed in the transformed cells—with no detectable expression in the normal epithelia—where it directly interacts with AR to enable its binding at chimeric AR half-motifs in concert with FOXA1 or other driver oncogenes. The gene discussed is FOXA1; the disease is posterior cortical atrophy.